Severance Hospital starts heavy ion therapy in lung cancer patients < Hospital < Article

Severance Hospital has commenced heavy ion therapy for lung cancer patients, with the first treatment administered to a 65-year-old male patient, identified only by his surname, Kim.Diagnosed with...

Lung Cancer—Patient Version

The two main types of lung cancer are non-small cell lung cancer and small cell lung cancer. Smoking causes most lung cancers, but nonsmokers can also develop lung cancer. Start here to find inform...

European patients begin receiving world’s first lung cancer vaccine in 'revolutionary' new trial | Euron....

A lung cancer patient in the UK has become one of the first to participate in a groundbreaking trial for the world's first vaccine against the disease.

Nearly half of Korean lung cancer patients found in stage 4. Why? < Hospital < A - KBR

According to the 2020 National Cancer Registry Statistics, the five-year survival rate for lung cancer patients in Korea is 36.8 percent. Why is the survival rate of lung cancer patients so low? "N...

Small Cell Lung Cancer - Guidelines for Patients Details

Small Cell Lung Cancer · Small Cell Lung Cancer - Arabic · Small Cell Lung Cancer - Chinese · Small Cell Lung Cancer - French · Small Cell Lung Cancer - Hindi · Small Cell Lung Cancer - Polish · Small Cell Lung Cancer - Portuguese · Small Cell Lung Cancer - Spanish

Lung Cancer Surgery | American Lung Association

Lung cancer surgery is an option for some patients depending on the type, location and stage of their lung cancer and other medical conditions.

Do lung cancer patients need molecular profiling?

Molecular profiling can offer some lung cancer patients a personalized treatment approach that’s often more effective than chemotherapy. Anne Tsao, M.D., shares who should receive genetic testing a...

World-first lung cancer vaccine trials launched across seven countries | Lung cancer

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back

Sugemalimab approved to treat adult patients with non-small cell lung cancer - GOV.UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 30 October, approved the medicine sugemalimab (Eqjubi) to treat adult patients with a type of lung cancer called ‘non-small...

Non-Small Cell Lung Cancer Treatment

Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Laser therapy, photodynamic therapy, cryosurgery, and ele...